SRRK · Scholar Rock Holding Corp
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-01 | FLIER JEFFREY S. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This sale was effected pursuant to a Rule 10b-5-1 trading plan adopted on March 31, 2026 to cover tax obligations upon the vesting and settlement of restricted stock units (RSUs). The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.805 to $55.010, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Consists of 21,017 shares of common stock and 6,839 RSUs. |
Common Stock
|
15 |
| 2026-07-01 | Gilman Michael |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This sale was effected pursuant to a Rule 10b-5-1 trading plan adopted on March 31, 2026 to cover tax obligations upon the vesting and settlement of restricted stock units (RSUs). The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.970 to $53.955, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Consists of 53,870 shares of common stock and 6,839 RSUs. |
Common Stock
|
1,346 |
| 2026-07-01 | Gilman Michael |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This sale was effected pursuant to a Rule 10b-5-1 trading plan adopted on March 31, 2026 to cover tax obligations upon the vesting and settlement of restricted stock units (RSUs). The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.790 to $55.010, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Consists of 52,672 shares of common stock and 6,839 RSUs. |
Common Stock
|
43 |
| 2026-07-01 | Peng Katie |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This sale was effected pursuant to a Rule 10b-5-1 trading plan adopted on March 20, 2026 to cover tax obligations upon the vesting and settlement of restricted stock units (RSUs). The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.967 to $54.815, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Consists of 21,521 shares of common stock and 12,801 RSUs. |
Common Stock
|
2,437 |
| 2026-07-01 | Reed Joshua |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This sale was effected pursuant to a Rule 10b-5-1 trading plan adopted on March 21, 2026 to cover tax obligations upon the vesting and settlement of restricted stock units (RSUs). The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.050 to $54.030, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Consists of 13,627 shares of common stock and 6,839 RSUs. |
Common Stock
|
2,105 |
| 2026-07-01 | Burow Kristina |
Director, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
This sale was effected pursuant to a Rule 10b-5-1 trading plan adopted on March 31, 2026 to cover tax obligations upon the vesting and settlement of restricted stock units (RSUs). The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.040 to $54.795, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Consists of 107,818 shares of common stock and 6,839 RSUs. |
Common Stock
|
948 |
| 2026-07-01 | Reed Joshua |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This sale was effected pursuant to a Rule 10b-5-1 trading plan adopted on March 21, 2026 to cover tax obligations upon the vesting and settlement of restricted stock units (RSUs). The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.040 to $54.795, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Consists of 12,679 shares of common stock and 6,839 RSUs. |
Common Stock
|
948 |
| 2026-07-01 | Peng Katie |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This sale was effected pursuant to a Rule 10b-5-1 trading plan adopted on March 20, 2026 to cover tax obligations upon the vesting and settlement of restricted stock units (RSUs). The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.970 to $53.965, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Consists of 23,958 shares of common stock and 12,801 RSUs. |
Common Stock
|
2,988 |
| 2026-07-01 | Burow Kristina |
Director, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
This sale was effected pursuant to a Rule 10b-5-1 trading plan adopted on March 31, 2026 to cover tax obligations upon the vesting and settlement of restricted stock units (RSUs). The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.050 to $54.030, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Consists of 108,766 shares of common stock and 6,839 RSUs. |
Common Stock
|
2,105 |
| 2026-07-01 | Gilman Michael |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This sale was effected pursuant to a Rule 10b-5-1 trading plan adopted on March 31, 2026 to cover tax obligations upon the vesting and settlement of restricted stock units (RSUs). The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.960 to $54.750, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Consists of 52,715 shares of common stock and 6,839 RSUs. |
Common Stock
|
1,155 |
| 2026-07-01 | FLIER JEFFREY S. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This sale was effected pursuant to a Rule 10b-5-1 trading plan adopted on March 31, 2026 to cover tax obligations upon the vesting and settlement of restricted stock units (RSUs). The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.960 to $53.944, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Consists of 22,502 shares of common stock and 6,839 RSUs. |
Common Stock
|
1,568 |
| 2026-07-01 | Peng Katie |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This sale was effected pursuant to a Rule 10b-5-1 trading plan adopted on March 20, 2026 to cover tax obligations upon the vesting and settlement of restricted stock units (RSUs). The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.860 to $55.016, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Consists of 21,500 shares of common stock and 12,801 RSUs. |
Common Stock
|
21 |
| 2026-07-01 | FLIER JEFFREY S. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This sale was effected pursuant to a Rule 10b-5-1 trading plan adopted on March 31, 2026 to cover tax obligations upon the vesting and settlement of restricted stock units (RSUs). The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.950 to $54.800, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Consists of 21,032 shares of common stock and 6,839 RSUs. |
Common Stock
|
1,470 |
| 2026-06-04 | Peng Katie |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2027 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date. Consists of 26,201 shares of common stock and 13,546 RSUs. |
Common Stock
|
6,839 |
| 2026-06-04 | AKKARAJU SRINIVAS |
Director, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2027 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date. Consists of 21,132 shares of common stock and 6,839 RSUs. |
Common Stock
|
6,839 |
| 2026-06-04 | Gilman Michael |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting, subject to continued service to the Issuer through such date. |
Stock Option (Right to Buy)
|
4,310 |
| 2026-06-04 | Reed Joshua |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2027 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date. Consists of 15,732 shares of common stock and 6,839 RSUs. |
Common Stock
|
6,839 |
| 2026-06-04 | Gilman Michael |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2027 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date. Consists of 55,216 shares of common stock and 6,839 RSUs. |
Common Stock
|
6,839 |
| 2026-06-04 | Peng Katie |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting, subject to continued service to the Issuer through such date. |
Stock Option (Right to Buy)
|
4,310 |
| 2026-06-04 | Reed Joshua |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting, subject to continued service to the Issuer through such date. |
Stock Option (Right to Buy)
|
4,310 |
| 2026-06-04 | Brudnick Richard |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2027 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date. Consists of 15,057 shares of common stock and 6,839 RSUs. |
Common Stock
|
6,839 |
| 2026-06-04 | FLIER JEFFREY S. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting, subject to continued service to the Issuer through such date. |
Stock Option (Right to Buy)
|
4,310 |
| 2026-06-04 | Burow Kristina |
Director, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2027 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date. Consists of 110,871 shares of common stock and 6,839 RSUs. |
Common Stock
|
6,839 |
| 2026-06-04 | Burow Kristina |
Director, 10% Owner |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting, subject to continued service to the Issuer through such date. |
Stock Option (Right to Buy)
|
4,310 |
| 2026-06-04 | AKKARAJU SRINIVAS |
Director, 10% Owner |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting, subject to continued service to the Issuer through such date. |
Stock Option (Right to Buy)
|
4,310 |
| 2026-06-04 | Brudnick Richard |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Options to vest and become fully exercisable on the earlier of the first anniversary following the date of grant or on the date of the Issuer's next Annual Meeting, subject to continued service to the Issuer through such date. |
Stock Option (Right to Buy)
|
4,310 |
| 2026-06-04 | FLIER JEFFREY S. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest on the earlier of June 15, 2027 or on the date of the Issuer's next Annual Meeting subject to continued service to the Issuer through such date. Consists of 24,070 shares of common stock and 6,839 RSUs. |
Common Stock
|
6,839 |
| 2026-04-23 | Burow Kristina |
Director, 10% Owner |
Convert↑
Filing footnotes — Common Stock (Direct)
Consists of 85,239 shares of common stock and 7,632 RSUs. |
Common Stock
|
36,000 |
| 2026-04-23 | Burow Kristina |
Director, 10% Owner |
Convert↑
Filing footnotes — Common Stock (Direct)
Consists of 103,239 shares of common stock and 7,632 RSUs. |
Common Stock
|
18,000 |
| 2026-04-23 | Burow Kristina |
Director, 10% Owner |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This stock option vested on May 26, 2023. No shares remain unvested under this stock option. |
Stock Option (Right to Buy)
|
28,000 |
| 2026-04-23 | Burow Kristina |
Director, 10% Owner |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This stock option vested on June 21, 2024. No shares remain unvested under this stock option. |
Stock Option (Right to Buy)
|
36,000 |
| 2026-04-23 | Burow Kristina |
Director, 10% Owner |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This stock option vested on May 22, 2025. No shares remain unvested under this stock option. |
Stock Option (Right to Buy)
|
18,000 |
| 2026-04-23 | Burow Kristina |
Director, 10% Owner |
Convert↑
Filing footnotes — Common Stock (Direct)
Consists of 21,239 shares of common stock and 7,632 RSUs. |
Common Stock
|
7,800 |
| 2026-04-23 | Burow Kristina |
Director, 10% Owner |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This stock option vested on May 26, 2022. No shares remain unvested under this stock option. |
Stock Option (Right to Buy)
|
7,800 |
| 2026-04-23 | Burow Kristina |
Director, 10% Owner |
Convert↑
Filing footnotes — Common Stock (Direct)
Consists of 49,239 shares of common stock and 7,632 RSUs.. |
Common Stock
|
28,000 |
| 2026-04-16 | Vaishnaw Akshay |
Director, President of R&D |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSUs") on April 15, 2026. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person. The shares vested pursuant to awards that were granted on April 27, 2025. Each RSU represents the contingent right to receive upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over four years, subject to a continued service relationship with the Issuer on the applicable vesting date. Consists of 58,521 shares of common stock, 122,021 RSUs subject to time-based vesting conditions and 450,000 RSUs subject to performance- and time-based vesting conditions. |
Common Stock
|
12,246 |
| 2026-04-16 | Hallal David |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSUs") on April 15, 2026. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person. The shares vested pursuant to awards that were granted on April 27, 2025. Each RSU represents the contingent right to receive upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over four years, subject to a continued service relationship with the Issuer on the applicable vesting date. Consists of 198,530 shares of common stock, 315,504 RSUs subject to time-based vesting conditions and 1,125,000 RSUs subject to performance- and time-based vesting conditions. |
Common Stock
|
30,615 |
| 2026-04-16 | Sinha Vikas |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSUs") on April 15, 2026. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person. The shares vested pursuant to awards that were granted on April 27, 2025. Each RSU represents the contingent right to receive upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over four years, subject to a continued service relationship with the Issuer on the applicable vesting date. Consists of 47,835 shares of common stock, 122,021 RSUs subject to time-based vesting conditions and 450,000 RSUs subject to performance- and time-based vesting conditions. |
Common Stock
|
10,410 |
| 2026-04-16 | Woods Keith |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSUs") on April 15, 2026. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person. The shares vested pursuant to awards that were granted on April 27, 2025. Each RSU represents the contingent right to receive upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over four years, subject to a continued service relationship with the Issuer on the applicable vesting date. Consists of 48,034 shares of common stock, 122,021 RSUs subject to time-based vesting conditions and 450,000 RSUs subject to performance- and time-based vesting conditions. |
Common Stock
|
10,220 |
| 2026-02-23 | Qatanani Mo |
CHIEF SCIENTIFIC OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2025. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.55 to $48.19, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Consists of 200 shares of common stock and 98,445 RSUs. |
Common Stock
|
857 |
| 2026-02-23 | Qatanani Mo |
CHIEF SCIENTIFIC OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2025. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.30 to $48.66, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Consists of 98,445 RSUs. |
Common Stock
|
200 |
| 2026-02-23 | Qatanani Mo |
CHIEF SCIENTIFIC OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2025. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.52 to $47.48, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Consists of 1,057 shares of common stock and 98,445 RSUs. |
Common Stock
|
7,427 |
| 2026-02-17 | Parlavecchio Caryn |
CHRO |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on February 15, 2026. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person. The shares vested pursuant to awards that were granted on February 13, 2023 and March 10, 2025. Each RSU represents the contingent right to receive upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over four years, subject to a continued service relationship with the Issuer on the applicable vesting date. (2) Consists of 86,859 shares of common stock and 82,228 RSUs. |
Common Stock
|
9,035 |
| 2026-02-17 | Ho Junlin |
GENERAL COUNSEL |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on February 15, 2026. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person. The shares vested pursuant to awards that were granted on February 13, 2023 and March 10, 2025. Each RSU represents the contingent right to receive upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over four years, subject to a continued service relationship with the Issuer on the applicable vesting date. Consists of 131,646 shares of common stock and 109,899 RSUs. |
Common Stock
|
9,580 |
| 2026-02-17 | Marantz Jing L. |
CHIEF MEDICAL OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on February 15, 2026. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person. The shares vested pursuant to awards that were granted on February 13, 2023 and March 10, 2025. Each RSU represents the contingent right to receive upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over four years, subject to a continued service relationship with the Issuer on the applicable vesting date. Consists of 29,388 shares of common stock and 96,624 RSUs. |
Common Stock
|
4,157 |
| 2026-02-17 | Qatanani Mo |
CHIEF SCIENTIFIC OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on February 15, 2026. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person. The shares vested pursuant to awards that were granted on February 13, 2023 and March 10, 2025. Each RSU represents the contingent right to receive upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over four years, subject to a continued service relationship with the Issuer on the applicable vesting date. Consists of 8,484 shares of common stock and 98,445 RSUs. |
Common Stock
|
7,989 |
| 2026-02-09 | Sinha Vikas |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units ("RSUs") subject to time-based vesting conditions. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment to vest on January 15, 2027 and each additional installment to vest annually thereafter; provided the reporting person continues to have a service relationship with the Issuer on each such vesting date. Consists of 33,245 shares of common stock, 147,021 RSUs subject to time-based vesting conditions and 450,000 RSUs subject to performance- and time-based vesting conditions. |
Common Stock
|
47,021 |
| 2026-02-09 | Vaishnaw Akshay |
Director, President of R&D |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units ("RSUs") subject to time-based vesting conditions. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment to vest on January 15, 2027 and each additional installment to vest annually thereafter; provided the reporting person continues to have a service relationship with the Issuer on each such vesting date. Consists of 45,767 shares of common stock, 147,021 RSUs subject to time-based vesting conditions and 450,000 RSUs subject to performance- and time-based vesting conditions. |
Common Stock
|
47,021 |
| 2026-02-09 | Woods Keith |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units ("RSUs") subject to time-based vesting conditions. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment to vest on January 15, 2027 and each additional installment to vest annually thereafter; provided the reporting person continues to have a service relationship with the Issuer on each such vesting date. Consists of 33,254 shares of common stock, 147,021 RSUs subject to time-based vesting conditions and 450,000 RSUs subject to performance- and time-based vesting conditions. |
Common Stock
|
47,021 |
| 2026-02-09 | Marantz Jing L. |
CHIEF MEDICAL OFFICER |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units ("RSUs") subject to time-based vesting conditions. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to this RSU vest in four annual installments over four years, with the first annual installment to vest on January 15, 2027 and each additional installment to vest annually thereafter; provided the reporting person continues to have a service relationship with the Issuer on each such vesting date. Consists of 24,974 shares of common stock and 105,195 RSUs. |
Common Stock
|
34,482 |